Intest Res.  2024 Jul;22(3):297-309. 10.5217/ir.2023.00129.

Intestinal ultrasound for intestinal Behçet disease reflects endoscopic activity and histopathological findings

Affiliations
  • 1Inflammatory Bowel Disease Center, Yokohama City University Medical Center, Yokohama, Japan
  • 2Department of Gastroenterology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan
  • 3Department of Laboratory Medicine and Clinical Investigation, Yokohama City University Medical Center, Yokohama, Japan
  • 4Department of Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan
  • 5Department of Molecular Pathology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan
  • 6Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan

Abstract

Background/Aims
Intestinal Behçet disease is typically associated with ileocecal punched-out ulcers and significant morbidity and mortality. Intestinal ultrasound is a noninvasive imaging technique for disease monitoring. However, no previous reports have compared intestinal ultrasound with endoscopic ulcer activity or histopathological findings for intestinal Behçet disease. We evaluated the usefulness of intestinal ultrasound for assessing the activity of ileocecal ulcers in intestinal Behçet disease.
Methods
We retrospectively compared intestinal ultrasound findings with 73 corresponding endoscopic images and 6 resected specimens. The intestinal ultrasound findings were assessed for 7 parameters (bowel wall thickness, vascularity [evaluated using the modified Limberg score with color Doppler], bowel wall stratification, white-plaque sign [strong hyperechogenic lines or spots], mesenteric lymphadenopathy, extramural phlegmons, and fistulas), and endoscopic ulcer activity was classified into active, healing, and scar stages. Histopathological findings were evaluated by consensus among experienced pathologists.
Results
Bowel wall thickness (P< 0.001), vascularity (P< 0.001), loss of bowel wall stratification (P= 0.015), and white-plague sign (P= 0.013) were significantly exacerbated in the endoscopic active ulcer stage. Receiver operating characteristic curve analysis revealed that a bowel wall thickness of > 5.5 mm (sensitivity 89.7%, specificity 85.3%) was potentially useful for detecting active lesions. When compared with histopathological findings, an increase in bowel wall thickness reflected the ulcer marginal ridge, and the white-plaque sign reflected the ulcer bottom.
Conclusions
Intestinal ultrasound is useful for monitoring intestinal ulcer activity in intestinal Behçet disease.

Keyword

Behçet disease; Intestinal diseases; Ultrasonography; Ulcer; Endoscopy

Reference

1. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med. 1999; 341:1284–1291.
Article
2. James DG. Behcet’s syndrome. N Engl J Med. 1979; 301:431–432.
3. He K, Yan X, Wu D. Intestinal Behcet’s disease: a review of the immune mechanism and present and potential biological agents. Int J Mol Sci. 2023; 24:8176.
Article
4. Skef W, Hamilton MJ, Arayssi T. Gastrointestinal Behçet’s disease: a review. World J Gastroenterol. 2015; 21:3801–3812.
Article
5. Hatemi I, Esatoglu SN, Hatemi G, Erzin Y, Yazici H, Celik AF. Characteristics, treatment, and long-term outcome of gastrointestinal involvement in Behcet’s syndrome: a strobe-compliant observational study from a dedicated multidisciplinary center. Medicine (Baltimore). 2016; 95:e3348.
6. Nguyen A, Upadhyay S, Javaid MA, et al. Behcet’s disease: an in-depth review about pathogenesis, gastrointestinal manifestations, and management. Inflamm Intest Dis. 2021; 6:175–185.
Article
7. Watanabe K, Tanida S, Inoue N, et al. Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet’s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants. J Gastroenterol. 2020; 55:679–700.
Article
8. Cheon JH, Kim WH. An update on the diagnosis, treatment, and prognosis of intestinal Behçet’s disease. Curr Opin Rheumatol. 2015; 27:24–31.
Article
9. Hatemi G, Christensen R, Bang D, et al. 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Ann Rheum Dis. 2018; 77:808–818.
Article
10. He K, Wu D. The treatment principles and targets for intestinal Behcet’s disease. Therap Adv Gastroenterol. 2023; 16:17562848231167283.
Article
11. Maaser C, Sturm A, Vavricka SR, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019; 13:144–164.
Article
12. Kucharzik T, Wittig BM, Helwig U, et al. Use of intestinal ultrasound to monitor Crohn’s disease activity. Clin Gastroenterol Hepatol. 2017; 15:535–542.
Article
13. Kucharzik T, Tielbeek J, Carter D, et al. ECCO-ESGAR topical review on optimizing reporting for cross-sectional imaging in inflammatory bowel disease. J Crohns Colitis. 2022; 16:523–543.
Article
14. Rimola J, Torres J, Kumar S, Taylor SA, Kucharzik T. Recent advances in clinical practice: advances in cross-sectional imaging in inflammatory bowel disease. Gut. 2022; 71:2587–2597.
Article
15. Ilvemark JF, Hansen T, Goodsall TM, et al. Defining transabdominal intestinal ultrasound treatment response and remission in inflammatory bowel disease: systematic review and expert consensus statement. J Crohns Colitis. 2022; 16:554–580.
Article
16. Peker E, Erden A, Erden İ, Düzgün N. Intestinal Behçet disease: evaluation with MR enterography: a case-control study. AJR Am J Roentgenol. 2018; 211:767–775.
Article
17. You JK, Kim MJ, Park S, Chung JJ, Kim WH. Intestinal Behçet’s disease: breath-hold MR imaging. Abdom Imaging. 2001; 26:309–314.
Article
18. Yang H, Zhang H, Liu W, et al. Computed tomography enterography increases the ability of endoscopy to differentiate Crohn’s disease from intestinal Behçet’s disease. Front Med (Lausanne). 2022; 9:900458.
Article
19. Park MJ, Lim JS. Computed tomography enterography for evaluation of inflammatory bowel disease. Clin Endosc. 2013; 46:327–366.
Article
20. Ma L, Wang M, Li W, et al. Pilot case-control study to explore the value of intestinal ultrasound in the differentiation of two common diseases involving the ileocecal region: intestinal Behçet’s disease and Crohn’s disease. Quant Imaging Med Surg. 2021; 11:3200–3208.
21. Cheon JH, Kim ES, Shin SJ, et al. Development and validation of novel diagnostic criteria for intestinal Behçet’s disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol. 2009; 104:2492–2499.
Article
22. Maconi G, Nylund K, Ripolles T, et al. EFSUMB recommendations and clinical guidelines for intestinal ultrasound (GIUS) in inflammatory bowel diseases. Ultraschall Med. 2018; 39:304–317.
Article
23. Kaneko E, Hoshihara Y, Sakaki N, et al. Peptic ulcer recurrence during maintenance therapy with H2-receptor antagonist following first-line therapy with proton pump inhibitor. J Gastroenterol. 2000; 35:824–831.
Article
24. Tanida S, Inoue N, Kobayashi K, et al. Adalimumab for the treatment of Japanese patients with intestinal Behçet’s disease. Clin Gastroenterol Hepatol. 2015; 13:940–948.
Article
25. Limberg B. Diagnosis of chronic inflammatory bowel disease by ultrasonography. Z Gastroenterol. 1999; 37:495–508.
26. Sasaki T, Kunisaki R, Kinoshita H, et al. Doppler ultrasound findings correlate with tissue vascularity and inflammation in surgical pathology specimens from patients with small intestinal Crohn’s disease. BMC Res Notes. 2014; 7:363.
Article
27. Taylor SA, Avni F, Cronin CG, et al. The first joint ESGAR/ ESPR consensus statement on the technical performance of crosssectional small bowel and colonic imaging. Eur Radiol. 2017; 27:2570–2582.
Article
28. Ripollés T, Martínez-Pérez MJ, Paredes JM, Vizuete J, GarcíaMartínez E, Jiménez-Restrepo DH. Contrast-enhanced ultrasound in the differentiation between phlegmon and abscess in Crohn’s disease and other abdominal conditions. Eur J Radiol. 2013; 82:e525–e531.
Article
29. Kunihiro K, Hata J, Haruma K, Manabe N, Tanaka S, Chayama K. Sonographic detection of longitudinal ulcers in Crohn disease. Scand J Gastroenterol. 2004; 39:322–326.
Article
30. Wang F, Numata K, Yonezawa H, et al. Consistency of trans-abdominal and water-immersion ultrasound images of diseased intestinal segments in Crohn’s disease. Diagnostics (Basel). 2020; 10:267.
Article
31. De Voogd F, Wilkens R, Gecse K, et al. A reliability study: strong inter-observer agreement of an expert panel for intestinal ultrasound in ulcerative colitis. J Crohns Colitis. 2021; 15:1284–1290.
Article
32. Sagami S, Kobayashi T, Miyatani Y, et al. Accuracy of ultrasound for evaluation of colorectal segments in patients with inflammatory bowel diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2021; 19:908–921.
Article
33. Lee CR, Kim WH, Cho YS, et al. Colonoscopic findings in intestinal Behçet’s disease. Inflamm Bowel Dis. 2001; 7:243–249.
Article
34. Bhatnagar G, Quinn L, Higginson A, et al. Observer agreement for small bowel ultrasound in Crohn’s disease: results from the METRIC trial. Abdom Radiol (NY). 2020; 45:3036–3045.
Article
35. Kinoshita K, Katsurada T, Nishida M, et al. Usefulness of transabdominal ultrasonography for assessing ulcerative colitis: a prospective, multicenter study. J Gastroenterol. 2019; 54:521–529.
Article
Full Text Links
  • IR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr